JSM 2011 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Activity Details
|
|||
516 * | Wed, 8/3/2011, 10:30 AM - 12:20 PM | CC-D233 | |
Issues in Adaptive Clinical Trials 1 — Contributed Papers | |||
Biopharmaceutical Section | |||
Chair(s): Rima Izem, U.S. Food and Drug Administration/CDER | |||
10:35 AM | Adaptive Blinded Sample Size Adjustment for Comparing Two Normal Means: A Mostly Bayesian Approach — Andrew Montgomery Hartley, PPD | ||
10:50 AM | Proposal for a Two-Stage Adaptive Dose-Response Trial Design Using Repeated Measures Data — Anjela Tzontcheva, Merck Research Laboratories ; Susan Huyck, Merck Research Laboratories | ||
11:05 AM | A Three-Part Adaptive Design with POC and Dose-Finding for Induction Regimen and Dose-Finding for Maintenance Regimen for an Immunology Trial — Usha Barai, Merck Research Laboratories | ||
11:20 AM | Adaptive Design for Bioequivalence Clinical Trials — Fengjuan Xuan, Merck & Co., Inc. ; Ferdous Gheyas, Merck & Co., Inc. | ||
11:35 AM | Adaptive Clinical Trial Design and Simulation of a Phase II Migraine Headache Proof-of-Concept Study Using Adaptive Design Explorer — Inna Perevozskaya, Pfizer Inc. ; Jihao Zhou, Pfizer Inc. ; Pamela D. Garzone, Pfizer Inc. ; Phil Stanley, Pfizer Inc. ; John P. Huggins, Pfizer Inc. ; Gilbert Y. Wong, Pfizer Inc. ; Ronald G. Menton, Pfizer Inc. | ||
12:05 PM | Martingale-Based Estimators Following Group Sequential/Adaptive Designs — Venkata Goteti, Merck & Co., Inc. ; Rongqi Chen, University of California at Davis ; Navdeep Boparai, Merck & Co., Inc. | ||
12:05 PM | Floor Discussion |
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.